Title:
USE OF LANOSTANES AND EXTRACTS FROM PORIA COCOS FOR TREATING CACHEXIA
Document Type and Number:
WIPO Patent Application WO/2010/127557
Kind Code:
A1
Abstract:
A pharmaceutical composition for treating cachexia, especially cachexia induced by cancer, comprising lanostanes as effective constituents. The suitable source of the lanostanes is the extracts from Poria cocos which comprise 1-60% (by weight) lanostanes without secolanostanes substantially. The extracts are extracted from the metabolite, fermented product or mycelium of Poria cocos (Schw) Wolf (Polyporaceae plant).
Inventors:
LIN HANG-CHING (CN)
Application Number:
PCT/CN2010/000627
Publication Date:
November 11, 2010
Filing Date:
May 04, 2010
Export Citation:
Assignee:
SINPHAR TIAN LI PHARMACEUTICAL (CN)
International Classes:
A61K36/076; A61K31/575; A61P43/00
Other References:
ZHANG MIN ET AL.: "Pharmacological Mechanisms and Advancement of Poria cocos.", JOURNAL OF BEIHUA UNIVERSITY, vol. 9, no. 1, February 2008 (2008-02-01), pages 63 - 68
LIN DONGXING.: "Research of Ganoderma lucidum in Adjunctive Therapy of Cancer.", EDIBLE FUNGI OF CHINA, vol. 19, no. 1, 2000, pages 3 - 5
ZENG XIANGLI: "Advances of researches on Triterpene Constituents and Pharmacology of Ganoderma lucidum.", JOURNAL OF FUNGAL RESEARCH, vol. 2, no. 1, 2004, pages 68 - 77
BAI JIANPING ET AL.: "Review on the Research of Cancer Cachexia.", ZHEJIANG JITCWM, vol. 13, no. 3, 2003, pages 197 - 199
LIN DONGXING.: "Research of Ganoderma lucidum in Adjunctive Therapy of Cancer.", EDIBLE FUNGI OF CHINA, vol. 19, no. 1, 2000, pages 3 - 5
ZENG XIANGLI: "Advances of researches on Triterpene Constituents and Pharmacology of Ganoderma lucidum.", JOURNAL OF FUNGAL RESEARCH, vol. 2, no. 1, 2004, pages 68 - 77
BAI JIANPING ET AL.: "Review on the Research of Cancer Cachexia.", ZHEJIANG JITCWM, vol. 13, no. 3, 2003, pages 197 - 199
Attorney, Agent or Firm:
PANAWELL & PARTNERS, LLC (18th FloorTower 2, Xihuan Plaza,1 Xizhimenwai Street, Xicheng District, Beijing 4, CN)
Download PDF: